NLMSF Logo
NLMSF Logo
Medical Information

Treatment Options

Comprehensive information about soft tissue sarcoma treatment approaches, including surgery, radiation, chemotherapy, and targeted therapies.

Medical TeamSurgeryTherapies

How Soft Tissue Sarcomas Are Treated

This information is adapted from medical resources including the American Cancer Society's Cancer Information Database. It is intended to help you and your family make informed decisions together with your medical team.

The treatment information in this section is not official policy of the National Leiomyosarcoma Foundation and is not intended as medical advice to replace the expertise and judgment of your cancer care team.

Your doctor may suggest treatment options different from these general guidelines. Don't hesitate to ask questions about your specific treatment plan.

The Multidisciplinary Care Team

Multidisciplinary care (MDC) can be broadly defined as an integrated team approach to health care in which medical and allied health care professionals consider all relevant treatment options and develop an individual treatment plan for each patient collaboratively.

Sarcoma care can be complex. Due to the large number and range of healthcare providers who may be involved, there is a potential for poor communication and poor coordination of care. MDC has been identified as a key enabler in the provision of high-quality treatment and care for cancer patients.

Multidisciplinary teams (MDTs) aim at improving communication, coordination, and decision-making between the care professionals.

Multidisciplinary care teams are a requirement of sarcoma centers of excellence.

SARC Sarcoma Centers Directory - Sarcoma Centers of Excellence

Core Members of the Multidisciplinary Sarcoma Team

  • Medical Oncologist
  • Surgical Oncologist
  • Radiation Oncologist
  • Pathologist
  • Diagnostic Radiologist
  • Nurse Coordinator

These members meet to discuss each patient to determine the best course of treatment. Nurse coordinators often bring patient information and concerns to the meeting.

Other professionals involved in the overall care of the patient may include:

  • Occupational and Physical Therapists
  • Social Workers
  • Integrative Medicine Doctors
  • Dieticians
  • Palliative Care Doctors

Surgery

The only way to cure a soft tissue sarcoma is to remove it with surgery, so surgery is part of the treatment for all soft tissue sarcomas whenever possible.

It is important that your surgeon and other doctors are experienced in the treatment of sarcomas. These are difficult tumors to treat and require both experience and expertise. Studies have shown that patients with sarcomas have better outcomes when they are treated at specialized cancer centers that have experience in sarcoma treatment.

Surgical Outcomes

Surgery aims to remove the tumor along with a margin of normal tissue around it.

  • The size and location of the tumor
  • The grade of the tumor
  • Whether clean margins can be achieved
  • The experience of the surgical team

After surgery, if the original tumor was surgically removed with clean margins and there are no signs of any other LMS, doctors might suggest either:

  • Wait & Watch approach with regular monitoring
  • Adjuvant treatment with chemotherapy and/or radiation

Radiation Therapy

Radiation therapy uses high-energy rays or particles to kill cancer cells.

  • Before surgery (neoadjuvant) to shrink the tumor and make it easier to remove
  • After surgery (adjuvant) to kill any remaining cancer cells
  • As the main treatment if surgery is not possible
  • To help relieve symptoms such as pain in advanced cancer

Types of Radiation Therapy

External Beam Radiation

Most common type of radiation therapy, where radiation is focused from a machine outside the body.

  • 3D Conformational Radiation Therapy - most commonly used
  • Intensity-Modulated Radiation Therapy (IMRT)
  • Stereotactic Body Radiation Therapy (SBRT)
Brachytherapy

Internal radiation using radioactive material placed directly into or near the tumor.

Side effects of radiation therapy can include skin changes, fatigue, and effects on nearby organs. Discuss potential side effects with your radiation oncologist before beginning treatment.

Chemotherapy

Chemotherapy uses anti-cancer drugs that are typically given intravenously or taken by mouth. These drugs enter the bloodstream and reach all areas of the body, making this treatment potentially useful for cancers that have spread beyond the original site.

Chemotherapy might be given:

  • Before surgery (neoadjuvant chemotherapy) to try to shrink the tumor
  • After surgery (adjuvant chemotherapy) to lower the risk of the cancer coming back
  • As the main treatment for metastatic sarcoma that has spread to other parts of the body

Common Chemotherapy Drugs for Soft Tissue Sarcoma

  • Doxorubicin (Adriamycin)
  • Ifosfamide (Ifex)
  • Gemcitabine (Gemzar)
  • Docetaxel (Taxotere)
  • Dacarbazine (DTIC)
  • Epirubicin (Ellence)
  • Temozolomide (Temodar)
  • Vinorelbine (Navelbine)

These drugs are often used in combination to improve effectiveness.

Side effects of chemotherapy depend on the specific drugs, doses, and duration of treatment. Common side effects may include hair loss, mouth sores, loss of appetite, nausea and vomiting, fatigue, and increased risk of infections.

Targeted Therapy

Targeted therapy drugs specifically target certain genes, proteins, or the tissue environment that contributes to cancer growth and survival. These drugs are different from chemotherapy drugs, which attack all rapidly dividing cells.

Types of Targeted Therapy for Soft Tissue Sarcoma

Tyrosine Kinase Inhibitors

Drugs like pazopanib (Votrient) target blood vessel formation and other pathways. It may be used for certain advanced soft tissue sarcomas after chemotherapy.

mTOR Inhibitors

Sirolimus (Rapamune) and other mTOR inhibitors may be effective against some types of soft tissue sarcomas.

HDAC Inhibitors

For specific sarcoma subtypes, drugs that inhibit histone deacetylases (HDACs) may be effective.

Learn More About HDAC Inhibitors

HDAC inhibitors (Histone Deacetylase inhibitors) are a class of compounds that interfere with the function of histone deacetylases, enzymes that remove acetyl groups from histones, thereby regulating gene expression.

Key Points on HDAC Inhibitors:
  1. Mechanism of Action: HDAC inhibitors block deacetylation, promoting histone acetylation, which relaxes chromatin and enhances gene expression.
  2. Therapeutic Applications: Used in cancer treatment (e.g., cutaneous T-cell lymphoma) and under research for neurological and inflammatory conditions.
  3. Examples: FDA-approved agents include Vorinostat, Romidepsin, Belinostat, and Panobinostat.
  4. Challenges: Non-specificity can lead to side effects such as fatigue, nausea, and thrombocytopenia.

Research into targeted therapies for soft tissue sarcomas continues to evolve. Clinical trials may offer access to newer targeted therapy options.

Immunotherapy

Immunotherapy is a cancer treatment that boosts the body's immune system to fight cancer cells. It uses drugs or other substances to enhance immune responses, targeting cancer more precisely than traditional therapies. It can be used alone or with other treatments.

Palliative Care

Palliative care is a specialized, team-based approach for those living with a serious illness. It focuses on relieving symptoms, pain, and treatment-related side effects while helping patients and families navigate the emotional and practical challenges that can arise — at any stage of illness.

Palliative Care vs. Hospice Care

Palliative Care

The goal is to alleviate suffering and improve quality of life for people with serious illness. Specialists address pain, symptoms, and stress, working alongside your existing medical team — in the hospital, clinic, or at home — to help you live your best life for as long as possible.

Hospice Care

Hospice is an insurance benefit for people approaching the end of life (typically with a prognosis of six months or less). It provides comprehensive support focused on comfort, goals, and quality of life — often at home — for both patients and families.

What Does Palliative Care Address?

  • Physical symptoms (pain, nausea, fatigue)
  • Emotional and coping support
  • Spiritual needs
  • Caregiver needs
  • Practical and care navigation needs
  • Financial, legal, and employment concerns
  • Insurance questions
  • Family and team communication

Who Provides Palliative Care?

Interdisciplinary teams that may include palliative medicine physicians, advanced practice providers, nurses, social workers, chaplains, psychologists, and other specialists. They work alongside your oncology and primary teams.

Palliative care can be integrated at any time during cancer care — from diagnosis through survivorship — whenever symptom management, decision support, or psychosocial care could help. Many sarcoma centers of excellence include palliative care as a standard part of their protocols. Ask your oncology team for a referral.

NCCN Patient Guidelines (Shared by NLMSF)

  • Fatigue and Cancer
  • Palliative Care
  • Distress During Cancer Care

Research & Evidence

There is growing evidence that palliative care improves symptoms, quality of life, and care satisfaction for patients and families. The National Cancer Institute (NCI) supports palliative care research across many domains.

Palliative Care FAQ

What you need to know about palliative care

Palliative care is specialized, team-based support focused on symptom relief, communication, and quality of life for people living with serious illness. It can be provided alongside curative or life-prolonging treatments at any stage.

What is palliative care?

An extra layer of support that treats pain, symptoms, and stress, and helps with decision-making, care coordination, and emotional well-being for patients and families.

Who gives palliative care?

Interdisciplinary teams that may include palliative medicine physicians, advanced practice providers, nurses, social workers, chaplains, psychologists, and other specialists. They work with your oncology and primary teams.

When is palliative care integrated into cancer care?

Anytime it can help — often early in the course of illness, at diagnosis, during active treatment, and through survivorship or advanced care. Many sarcoma centers include it as a standard part of care.

How do I access palliative care services?

Ask your oncology team for a referral. Services are available in hospitals, clinics, and at home. If not discussed, bring it up and request an evaluation.

How does palliative care differ from hospice care?

Palliative care can be provided at any stage alongside active treatment. Hospice focuses on comfort near the end of life (typically with a prognosis of six months or less) and prioritizes quality of life and goals of care.

Who pays for palliative care?

Coverage varies by insurance and setting. Many services are covered by Medicare, Medicaid, and private insurers; check your plan benefits and ask providers about covered services and any out-of-pocket costs.

Is there evidence that palliative care helps? Does NCI support palliative care research?

Studies show palliative care improves symptom control, patient and caregiver satisfaction, and can reduce healthcare burden. The National Cancer Institute supports research in palliative and supportive care across multiple programs.

Additional Resources

Treatment Planning

After a sarcoma is found and staged, your team will recommend one or several treatment options. This decision is important, so take time and think about all of the choices.

Factors to Consider When Choosing a Treatment Plan

  • The type, location, and stage of the cancer
  • Your overall physical health
  • Possible side effects of each treatment
  • Likelihood of controlling the cancer and/or relieving symptoms
  • Your preferences and goals
“It is important to discuss all of your treatment options, including their goals and possible side effects, with your doctors to help make the decision that best fits your needs.”

It's very important to ask questions if there is anything you're not sure about. You may want to seek a second opinion. A second opinion can provide more information and help you feel more confident about the chosen treatment plan. Some insurance companies require a second opinion before they will agree to pay for treatments.

Frequently Asked Questions

What are my best/most effective choices of treatment based on the location of my tumor and if it has spread to other sites in my body?

Treatment options depend on the tumor's location, size, stage, and whether it has metastasized. For localized sarcomas, surgery is often the primary treatment, potentially followed by radiation or chemotherapy. If the cancer has spread, systemic treatments like chemotherapy, targeted therapy, or immunotherapy may be recommended. Discuss with your multidisciplinary team to tailor a plan based on your specific case.

Finding a sarcoma center near me - how can I be helped to find a sarcoma specialist?

You can find a sarcoma specialist through the SARC Sarcoma Centers Directory at sarctrials.org. Additionally, contact the National Leiomyosarcoma Foundation or organizations like the Sarcoma Alliance for referrals to sarcoma centers of excellence near you.

Who is my oncology care team at a sarcoma center vs. a community provider setting?

At a sarcoma center, your care team typically includes a multidisciplinary team (MDT) with medical, surgical, and radiation oncologists, pathologists, radiologists, and nurse coordinators, plus support staff like social workers and dieticians. In a community setting, you may have a general oncologist and fewer specialized professionals, potentially limiting access to sarcoma-specific expertise.

Could I seek a second opinion and if so how can I proceed to obtain a second opinion?

Yes, seeking a second opinion is recommended to confirm your diagnosis and treatment plan. Contact a sarcoma center or use services like Included Health, Dana-Farber, or Stanford Medicine’s online second opinion programs. Gather your medical records (pathology reports, imaging, etc.) and check with your insurance for coverage.

Will genomic/molecular testing (and tell me the difference) of my tumor be possible and will it be retested if I have a recurrence?

Genomic testing analyzes the tumor’s DNA for broad genetic changes, while molecular testing targets specific molecules or pathways. Both are often possible and can guide targeted therapies. If a recurrence occurs, retesting is typically recommended to identify any new mutations, as the tumor’s profile may change.

Should I be considering a clinical trial ahead of standard of care? What are the pros and cons?

Clinical trials can offer access to cutting-edge treatments but may involve unproven therapies with uncertain outcomes. Pros include potential for better results and contributing to research; cons include possible side effects and logistical challenges. Discuss with your oncologist to weigh trials against standard treatments like surgery or chemotherapy.

How can I find help for financial assistance for medical bills, treatment costs, and other life management needs based on my inability to maintain my employment?

Contact social workers at your sarcoma center or organizations like the Sarcoma Alliance or CancerCare for financial aid resources. Programs like Medicaid, hospital charity care, or nonprofit grants can help. For life management, explore local support groups or services through the American Cancer Society.

Where can I find help to address health insurance issues and impediments to treatment? Am I eligible to apply for disability insurance?

Hospital social workers or patient navigators can assist with insurance issues. Organizations like Triage Cancer offer free guidance on insurance and disability. You may be eligible for Social Security Disability Insurance (SSDI) if your condition prevents work; contact the Social Security Administration or a legal advocate for help.

How do I improve my potential for best outcomes during treatment and after treatment is completed?

Work with a sarcoma center’s multidisciplinary team, adhere to your treatment plan, and maintain open communication with your doctors. Post-treatment, follow surveillance schedules, adopt a healthy lifestyle (nutrition, exercise), and seek integrative medicine support to optimize recovery and reduce recurrence risk.

What happens after treatment is completed - next steps to stay connected for check-ups and what will that entail?

After treatment, you’ll enter a surveillance phase with regular check-ups, including physical exams, imaging (e.g., CT, MRI), and blood tests to monitor for recurrence. Frequency varies but is typically every 3-6 months initially. Stay in touch with your oncology team for ongoing support.

How do I seek integrative medicine support – for nutrition, exercise, general physical and emotional support during and after treatment?

Ask your sarcoma center for integrative medicine services, which may include dieticians, physical therapists, and counselors. Organizations like the American Cancer Society offer resources for nutrition and exercise programs. Emotional support can be found through support groups or therapists specializing in oncology.

What complementary therapies are appropriate for me to see during treatment – oncological massage possibly and what is the difference between a regular massage and an oncological massage?

Complementary therapies like oncological massage, acupuncture, or yoga may help manage symptoms. Oncological massage is tailored for cancer patients, using gentle techniques to avoid complications like lymphedema, unlike regular massage. Consult your oncologist and seek therapists trained in oncology-specific care.

Is there supportive guidance for my family/caregiver to help me get through treatment and after treatment what happens next?

Sarcoma centers often provide caregiver support through social workers, support groups, or counseling. Organizations like CancerCare and the American Cancer Society offer caregiver resources. Post-treatment, caregivers can help with follow-up appointments and emotional support, guided by your care team.

How often do I have to be exposed to imaging studies in the first year, second year, and thereafter?

Imaging frequency depends on your sarcoma type and stage. Typically, in the first year, imaging (e.g., CT, MRI) occurs every 3-4 months; in the second year, every 4-6 months; and thereafter, every 6-12 months. Your oncologist will customize the schedule based on your risk of recurrence.